DHR-PB
Danaher Corporation [DHR-PB] Stock Forecast
Buy or Sell ? Support and Resistance
What is MACD and how to read it?
How RSI can help?
DHR-PB Stock Summary
Top 10 Correlated ETFs
DHR-PB
Top 10 Correlated Stocks
DHR-PB
In the News
DHR-PB Financial details
DHR-PB Financial Performance
Yearly Fundamentals Overview
Last date of statement is 2022-12-31
| Metric | History | 2018-12-31 | 2019-12-31 | 2020-12-31 | 2021-12-31 | 2022-12-31 |
|---|---|---|---|---|---|---|
| Revenue per share | 28.26 | 25.44 | 31.65 | 41.84 | 44.7 | |
| Net income per share | 3.77 | 4.27 | 5.18 | 9.14 | 10.09 | |
| Operating cash flow per share | 5.71 | 5.61 | 8.82 | 11.87 | 12.1 | |
| Free cash flow per share | 4.78 | 4.71 | 7.69 | 10.03 | 10.46 | |
| Cash per share | 1.12 | 28.28 | 8.57 | 3.67 | 8.52 | |
| Book value per share | 40.08 | 43 | 56.49 | 64.16 | 71.14 | |
| Tangible book value per share | -13.28 | -3.1 | -24.04 | -26.78 | -14.16 | |
| Share holders equity per share | 40.08 | 43 | 56.49 | 64.16 | 71.14 | |
| Interest debt per share | 14.06 | 31.24 | 31.89 | 33.39 | 28.25 | |
| Market cap | 704.79B | 704.79B | 915.97B | 1223.67B | 955.01B | |
| Enterprise value | 713.74B | 706.77B | 932.12B | 1244.36B | 968.69B | |
| P/E ratio | 265.87 | 234.29 | 251.23 | 190.22 | 134.45 | |
| Price to sales ratio | 35.43 | 39.35 | 41.1 | 41.55 | 30.35 | |
| POCF ratio | 175.23 | 178.36 | 147.55 | 146.41 | 112.1 | |
| PFCF ratio | 209.37 | 212.54 | 169.09 | 173.23 | 129.63 | |
| P/B Ratio | 24.98 | 23.28 | 23.03 | 27.09 | 19.07 | |
| PTB ratio | 24.98 | 23.28 | 23.03 | 27.09 | 19.07 | |
| EV to sales | 35.88 | 39.46 | 41.83 | 42.25 | 30.78 | |
| Enterprise value over EBITDA | 150.01 | 136.46 | 142.42 | 123.33 | 91.22 | |
| EV to operating cash flow | 177.46 | 178.86 | 150.15 | 148.88 | 113.71 | |
| EV to free cash flow | 212.03 | 213.13 | 172.07 | 176.15 | 131.49 | |
| Earnings yield | 0 | 0 | 0 | 0.01 | 0.01 | |
| Free cash flow yield | 0 | 0 | 0.01 | 0.01 | 0.01 | |
| Debt to equity | 0.69 | 1.05 | 0.91 | 0.84 | 0.68 | |
| Debt to assets | 0.41 | 0.51 | 0.48 | 0.46 | 0.41 | |
| Net debt to EBITDA | 1.88 | 0.38 | 2.47 | 2.05 | 1.29 | |
| Current ratio | 1.47 | 5.19 | 1.86 | 1.43 | 1.89 | |
| Interest coverage | 21.63 | 30.1 | 15.39 | 31.37 | 41.18 | |
| Income quality | 1.52 | 1.31 | 1.7 | 1.3 | 1.18 | |
| Dividend Yield | 0 | 0 | 0 | 0 | 0 | |
| Payout ratio | 0.16 | 0.18 | 0.17 | 0.12 | 0.12 | |
| Sales general and administrative to revenue | 0 | 0 | 0 | 0 | 0 | |
| Research and developement to revenue | 0.06 | 0.06 | 0.06 | 0.06 | 0.06 | |
| Intangibles to total assets | 0.79 | 0.52 | 0.74 | 0.77 | 0.71 | |
| Capex to operating cash flow | -0.16 | -0.16 | -0.13 | -0.15 | -0.14 | |
| Capex to revenue | -0.03 | -0.04 | -0.04 | -0.04 | -0.04 | |
| Capex to depreciation | -0.5 | -0.53 | -0.45 | -0.6 | -0.52 | |
| Stock based compensation to revenue | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | |
| Graham number | 58.27 | 64.3 | 81.13 | 114.85 | 127.08 | |
| ROIC | 0.06 | 0.12 | 0.06 | 0.08 | 0.11 | |
| Return on tangible assets | 0.26 | 0.1 | 0.19 | 0.34 | 0.29 | |
| Graham Net | -21.66 | -12.33 | -37.17 | -43.42 | -32.71 | |
| Working capital | 2.25B | 20.66B | 6.4B | 3.51B | 7.49B | |
| Tangible asset value | -9.35B | -2.18B | -16.93B | -18.85B | -9.97B | |
| Net current asset value | -12.51B | -6.2B | -22.58B | -26.36B | -18.39B | |
| Invested capital | 0.35 | 0.72 | 0.56 | 0.52 | 0.39 | |
| Average receivables | 3.51B | 3.34B | 3.62B | 4.34B | 4.77B | |
| Average payables | 1.61B | 1.61B | 1.78B | 2.31B | 2.43B | |
| Average inventory | 1.88B | 1.77B | 1.96B | 2.53B | 2.94B | |
| Days sales outstanding | 64.03 | 65.04 | 66.25 | 57.39 | 57.04 | |
| Days payables outstanding | 71.16 | 69.73 | 76.24 | 81.53 | 66.93 | |
| Days of inventory on hand | 79.35 | 74.97 | 85.29 | 87.81 | 90.65 | |
| Receivables turnover | 5.7 | 5.61 | 5.51 | 6.36 | 6.4 | |
| Payables turnover | 5.13 | 5.23 | 4.79 | 4.48 | 5.45 | |
| Inventory turnover | 4.6 | 4.87 | 4.28 | 4.16 | 4.03 | |
| ROE | 0.09 | 0.1 | 0.09 | 0.14 | 0.14 | |
| Capex per share | -0.93 | -0.9 | -1.12 | -1.84 | -1.64 |
Quarterly Fundamentals Overview
Last date of statement is 2022-12-31 for Q4
| Metric | History | 2021-12-31 | 2022-04-01 | 2022-07-01 | 2022-09-30 | 2022-12-31 |
|---|---|---|---|---|---|---|
| Revenue per share | 11.57 | 10.92 | 11.01 | 10.88 | 11.89 | |
| Net income per share | 2.54 | 2.45 | 2.39 | 2.2 | 3.14 | |
| Operating cash flow per share | 3.31 | 2.8 | 2.84 | 2.86 | 3.61 | |
| Free cash flow per share | 2.72 | 2.44 | 2.42 | 2.46 | 3.14 | |
| Cash per share | 3.67 | 5.28 | 5.66 | 7.32 | 8.52 | |
| Book value per share | 64.16 | 65.85 | 66.18 | 66.74 | 71.14 | |
| Tangible book value per share | -26.78 | -23.36 | -19.29 | -15.95 | -14.16 | |
| Share holders equity per share | 64.16 | 65.85 | 66.18 | 66.74 | 71.14 | |
| Interest debt per share | 33.14 | 31.01 | 28.57 | 27.4 | 28.04 | |
| Market cap | 1223.67B | 1105.89B | 943.11B | 948.63B | 955.01B | |
| Enterprise value | 1244.36B | 1123.95B | 959.19B | 962.73B | 968.69B | |
| P/E ratio | 171.1 | 160.27 | 140.34 | 152.91 | 108.03 | |
| Price to sales ratio | 150.18 | 143.85 | 121.68 | 123.79 | 114.11 | |
| POCF ratio | 524.51 | 561.93 | 471.56 | 471.96 | 375.84 | |
| PFCF ratio | 639.66 | 643.71 | 553.47 | 547.39 | 431.74 | |
| P/B Ratio | 27.09 | 23.86 | 20.24 | 20.19 | 19.07 | |
| PTB ratio | 27.09 | 23.86 | 20.24 | 20.19 | 19.07 | |
| EV to sales | 152.72 | 146.19 | 123.75 | 125.63 | 115.75 | |
| Enterprise value over EBITDA | 456.14 | 413.52 | 358.98 | 386.33 | 336.59 | |
| EV to operating cash flow | 533.37 | 571.11 | 479.6 | 478.97 | 381.23 | |
| EV to free cash flow | 650.47 | 654.22 | 562.91 | 555.53 | 437.93 | |
| Earnings yield | 0 | 0 | 0 | 0 | 0 | |
| Free cash flow yield | 0 | 0 | 0 | 0 | 0 | |
| Debt to equity | 0.84 | 0.8 | 0.76 | 0.72 | 0.68 | |
| Debt to assets | 0.46 | 0.44 | 0.43 | 0.42 | 0.41 | |
| Net debt to EBITDA | 7.58 | 6.64 | 6.02 | 5.66 | 4.75 | |
| Current ratio | 1.43 | 1.68 | 1.75 | 1.78 | 1.89 | |
| Interest coverage | 38.46 | 40.22 | 43.24 | 47.98 | 35.88 | |
| Income quality | 1.3 | 1.14 | 1.19 | 1.28 | 1.14 | |
| Dividend Yield | 0 | 0 | 0 | 0 | 0 | |
| Payout ratio | 0.11 | 0.11 | 0.13 | 0.13 | 0.09 | |
| Sales general and administrative to revenue | 0 | 0 | 0 | 0 | 0 | |
| Research and developement to revenue | 0.06 | 0.06 | 0.06 | 0.05 | 0.05 | |
| Intangibles to total assets | 0.77 | 0.75 | 0.74 | 0.72 | 0.71 | |
| Capex to operating cash flow | -0.18 | -0.13 | -0.15 | -0.14 | -0.13 | |
| Capex to revenue | -0.05 | -0.03 | -0.04 | -0.04 | -0.04 | |
| Capex to depreciation | -0.72 | -0.44 | -0.54 | -0.51 | -0.58 | |
| Stock based compensation to revenue | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | |
| Graham number | 60.55 | 60.25 | 59.61 | 57.52 | 70.89 | |
| ROIC | 0.02 | 0.02 | 0.03 | 0.02 | 0.03 | |
| Return on tangible assets | 0.09 | 0.08 | 0.08 | 0.07 | 0.09 | |
| Graham Net | -43.42 | -40.44 | -37.21 | -34.05 | -32.71 | |
| Working capital | 3.51B | 5.12B | 5.67B | 6.25B | 7.49B | |
| Tangible asset value | -18.85B | -16.45B | -13.58B | -11.23B | -9.97B | |
| Net current asset value | -26.36B | -24.36B | -21.98B | -19.8B | -18.39B | |
| Invested capital | 0.52 | 0.47 | 0.43 | 0.41 | 0.39 | |
| Average receivables | 4.41B | 4.52B | 4.47B | 4.47B | 4.66B | |
| Average payables | 2.35B | 2.46B | 2.39B | 2.31B | 2.24B | |
| Average inventory | 2.75B | 2.92B | 3.16B | 3.25B | 3.17B | |
| Days sales outstanding | 51.15 | 51.59 | 52.56 | 51.78 | 52.89 | |
| Days payables outstanding | 72.14 | 71.11 | 71.85 | 64.04 | 60.24 | |
| Days of inventory on hand | 77.7 | 92.69 | 96.74 | 94.59 | 81.6 | |
| Receivables turnover | 1.76 | 1.74 | 1.71 | 1.74 | 1.7 | |
| Payables turnover | 1.25 | 1.27 | 1.25 | 1.41 | 1.49 | |
| Inventory turnover | 1.16 | 0.97 | 0.93 | 0.95 | 1.1 | |
| ROE | 0.04 | 0.04 | 0.04 | 0.03 | 0.04 | |
| Capex per share | -0.6 | -0.36 | -0.42 | -0.39 | -0.47 |
DHR-PB Frequently Asked Questions
What is Danaher Corporation stock symbol ?
Danaher Corporation is a US stock , located in Washington of Dc and trading under the symbol DHR-PB
What is Danaher Corporation stock quote today ?
Danaher Corporation stock price is $1260.23999 today.
Is Danaher Corporation stock public?
Yes, Danaher Corporation is a publicly traded company.
Company Profile
- Volume Average 7.91K
- Market Capitalization 916.01B
- Employee 78K
- CEO Mr. Rainer M. Blair
- Headquarters Washington,DC,US
- IPO Date 2020-05-11
-
Website
https://www.danaher.com 
Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The company operates through three segments: Life Sciences, Diagnostics, and Environmental & Applied Solutions. The Life Sciences segment provides mass spectrometers; flow cytometry, genomics, lab automation, centrifugation, particle counting and characterization; microscopes; genomics consumables; and Gene and Cell Therapy. This segment also offers bioprocess technologies, consumables, and services; and filtration, separation, and purification technologies to the pharmaceutical and biopharmaceutical, food and beverage, medical, and life sciences companies, as well as universities, medical schools and research institutions, and various industrial manufacturers. The Diagnostics segment provides chemistry, immunoassay, microbiology, and automation systems, as well as hematology, molecular, acute care, and pathology diagnostics products. This segment offers clinical instruments, reagents, consumables, software, and services for hospitals, physicians' offices, reference laboratories, and other critical care settings. The Environmental & Applied Solutions segment offers instrumentation, consumables, software, services, and disinfection systems to analyze, treat, and manage ultra-pure, potable, industrial, waste, ground, source, and ocean water in residential, commercial, industrial, and natural resource applications. This segment also provides instruments, software, services, and consumables for various color and appearance management, packaging design and quality management, packaging converting, printing, marking, coding, and traceability applications for consumer, pharmaceutical, and industrial products. The company was formerly known as Diversified Mortgage Investors, Inc. and changed its name to Danaher Corporation in 1984. Danaher Corporation was founded in 1969 and is headquartered in Washington, the District of Columbia.
